Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Ana Gleisner

Concepts (332)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatectomy
39
2025
212
5.380
 Why?
Liver Neoplasms
39
2025
640
5.320
 Why?
Carcinoma, Hepatocellular
24
2025
272
4.770
 Why?
Pancreatic Neoplasms
24
2024
882
4.200
 Why?
Adenocarcinoma
25
2024
898
3.650
 Why?
Sentinel Lymph Node
8
2022
42
2.850
 Why?
Laparoscopy
9
2024
451
2.560
 Why?
Melanoma
12
2022
730
2.520
 Why?
Skin Neoplasms
12
2022
825
2.420
 Why?
Pancreaticoduodenectomy
11
2024
159
2.260
 Why?
Cholangiocarcinoma
10
2025
77
2.190
 Why?
Bile Duct Neoplasms
10
2025
99
2.110
 Why?
Lymph Node Excision
11
2024
164
2.080
 Why?
Pancreatectomy
7
2024
241
1.900
 Why?
Neoplasm Recurrence, Local
16
2025
964
1.690
 Why?
Postoperative Complications
18
2025
2483
1.680
 Why?
Sentinel Lymph Node Biopsy
11
2023
107
1.560
 Why?
Minimally Invasive Surgical Procedures
6
2025
170
1.500
 Why?
Retrospective Studies
76
2025
14518
1.310
 Why?
Survival Rate
32
2025
1877
1.280
 Why?
Tumor Burden
11
2025
286
1.210
 Why?
Aged
73
2025
22103
1.070
 Why?
Prognosis
36
2025
3794
1.060
 Why?
Databases, Factual
16
2025
1269
1.060
 Why?
Lymph Nodes
8
2024
472
0.980
 Why?
Liver Transplantation
11
2024
831
0.980
 Why?
Middle Aged
82
2025
31154
0.950
 Why?
Esophagectomy
4
2021
125
0.920
 Why?
Robotic Surgical Procedures
3
2019
115
0.860
 Why?
Esophageal Neoplasms
7
2023
295
0.860
 Why?
Lymphatic Metastasis
12
2025
320
0.840
 Why?
Conversion to Open Surgery
2
2020
15
0.830
 Why?
Thrombelastography
1
2024
150
0.830
 Why?
Breast Neoplasms
5
2024
2142
0.830
 Why?
Nomograms
2
2022
47
0.810
 Why?
Colorectal Neoplasms
9
2025
752
0.790
 Why?
Carcinoma, Pancreatic Ductal
5
2023
270
0.780
 Why?
Risk Assessment
16
2025
3240
0.750
 Why?
Humans
123
2025
129650
0.750
 Why?
Bilirubin
4
2025
96
0.740
 Why?
Rectal Neoplasms
5
2023
136
0.730
 Why?
Female
93
2025
68776
0.730
 Why?
Male
89
2025
63681
0.700
 Why?
Colonic Neoplasms
3
2024
243
0.610
 Why?
Serum Albumin
5
2025
149
0.610
 Why?
alpha-Fetoproteins
4
2025
41
0.580
 Why?
Quality of Life
2
2019
2704
0.570
 Why?
Neoplasm Staging
11
2025
1295
0.550
 Why?
Head and Neck Neoplasms
6
2019
544
0.550
 Why?
Follow-Up Studies
18
2025
4897
0.550
 Why?
Metastasectomy
3
2024
19
0.530
 Why?
Treatment Outcome
26
2025
10230
0.520
 Why?
Neoadjuvant Therapy
11
2023
383
0.510
 Why?
Peritoneal Neoplasms
3
2024
87
0.510
 Why?
Colectomy
3
2013
94
0.490
 Why?
Machine Learning
3
2025
443
0.490
 Why?
Liver Failure
3
2009
91
0.460
 Why?
Stomach Neoplasms
2
2024
99
0.420
 Why?
Axilla
3
2023
45
0.420
 Why?
Cytoreduction Surgical Procedures
3
2024
61
0.400
 Why?
Decision Making
1
2019
851
0.400
 Why?
Propensity Score
4
2024
265
0.390
 Why?
Aged, 80 and over
18
2024
7086
0.370
 Why?
Ampulla of Vater
2
2024
38
0.360
 Why?
Decision Support Techniques
2
2025
396
0.350
 Why?
Predictive Value of Tests
6
2025
1952
0.350
 Why?
Length of Stay
6
2025
1127
0.340
 Why?
ROC Curve
5
2025
503
0.340
 Why?
Neuroendocrine Tumors
2
2023
99
0.310
 Why?
Benchmarking
2
2021
176
0.310
 Why?
Single Photon Emission Computed Tomography Computed Tomography
2
2019
10
0.310
 Why?
Adult
36
2025
35576
0.310
 Why?
Gallbladder Neoplasms
2
2024
20
0.300
 Why?
Margins of Excision
4
2023
38
0.290
 Why?
CA-19-9 Antigen
2
2024
22
0.280
 Why?
Risk Factors
14
2025
9765
0.280
 Why?
Mastectomy, Segmental
2
2017
85
0.280
 Why?
Disease-Free Survival
8
2024
648
0.270
 Why?
Liver Cirrhosis
4
2025
280
0.260
 Why?
Catheter Ablation
2
2008
335
0.250
 Why?
Survival Analysis
7
2024
1274
0.250
 Why?
Hyperglycemia
2
2020
328
0.240
 Why?
Infusions, Intra-Arterial
1
2025
53
0.240
 Why?
Time Factors
8
2025
6556
0.240
 Why?
gamma-Glutamyltransferase
1
2025
42
0.240
 Why?
United States
16
2024
13903
0.240
 Why?
Hepatic Artery
1
2025
59
0.230
 Why?
Medical Futility
1
2025
24
0.230
 Why?
Anastomotic Leak
1
2024
38
0.230
 Why?
Abdomen, Acute
1
2004
18
0.230
 Why?
Blood Loss, Surgical
1
2025
93
0.230
 Why?
Quality Indicators, Health Care
2
2025
298
0.220
 Why?
Cohort Studies
10
2023
5420
0.220
 Why?
Preoperative Care
3
2024
340
0.220
 Why?
End Stage Liver Disease
1
2025
78
0.220
 Why?
Bacterial Infections
3
2006
237
0.220
 Why?
Proportional Hazards Models
4
2025
1201
0.220
 Why?
Chemotherapy, Adjuvant
6
2025
381
0.220
 Why?
Lymphopenia
1
2024
59
0.220
 Why?
Combined Modality Therapy
6
2024
1206
0.210
 Why?
Odds Ratio
4
2019
1023
0.210
 Why?
Practice Guidelines as Topic
2
2024
1501
0.210
 Why?
SEER Program
2
2014
206
0.210
 Why?
Time-to-Treatment
1
2024
180
0.210
 Why?
Multilocus Sequence Typing
1
2022
13
0.200
 Why?
Lymphoscintigraphy
2
2019
9
0.200
 Why?
Lung Neoplasms
3
2023
2344
0.200
 Why?
Surgical Oncology
1
2022
22
0.200
 Why?
Sunburn
1
2002
26
0.200
 Why?
Sunscreening Agents
1
2002
23
0.200
 Why?
Mastectomy
1
2023
131
0.200
 Why?
Nevus, Pigmented
1
2002
32
0.200
 Why?
Pelvic Exenteration
2
2019
11
0.190
 Why?
Klatskin Tumor
1
2021
14
0.190
 Why?
Anesthetics, Inhalation
1
2021
27
0.180
 Why?
Artificial Intelligence
1
2024
246
0.180
 Why?
Propofol
1
2021
60
0.180
 Why?
Chemoradiotherapy
4
2023
210
0.180
 Why?
Prospective Studies
8
2022
7133
0.170
 Why?
Organ Preservation
4
2023
94
0.170
 Why?
Hyperthermia, Induced
2
2020
109
0.170
 Why?
Registries
2
2021
1896
0.170
 Why?
Reoperation
3
2017
545
0.160
 Why?
Scalp
1
2019
34
0.160
 Why?
Kaplan-Meier Estimate
3
2025
857
0.160
 Why?
Anesthesia
1
2021
134
0.160
 Why?
Regression Analysis
2
2019
993
0.160
 Why?
Inflammation
3
2024
2736
0.160
 Why?
Neutrophils
1
2024
1205
0.150
 Why?
Pancreatic Diseases
1
2019
70
0.150
 Why?
Skin Pigmentation
1
2019
45
0.150
 Why?
Referral and Consultation
1
2024
732
0.150
 Why?
Tomography, X-Ray Computed
3
2025
2535
0.150
 Why?
Patient Acceptance of Health Care
1
2024
759
0.140
 Why?
Population Surveillance
1
2021
439
0.140
 Why?
Appendiceal Neoplasms
1
2017
26
0.140
 Why?
Neoplasms
2
2022
2470
0.140
 Why?
Common Bile Duct Neoplasms
1
2017
27
0.140
 Why?
Patient Compliance
1
2021
565
0.140
 Why?
Gastric Outlet Obstruction
1
2017
9
0.140
 Why?
Pylorus
1
2017
17
0.140
 Why?
Waiting Lists
2
2009
237
0.140
 Why?
Disease Management
1
2021
589
0.140
 Why?
Carcinoma, Ductal, Breast
1
2017
82
0.130
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2024
1565
0.130
 Why?
Radiotherapy, Intensity-Modulated
1
2018
129
0.130
 Why?
Hospitals, High-Volume
1
2016
39
0.130
 Why?
Cancer Care Facilities
1
2016
32
0.130
 Why?
Nutritional Status
1
2019
328
0.130
 Why?
Neuromuscular Agents
1
2017
31
0.130
 Why?
Botulinum Toxins, Type A
1
2017
41
0.130
 Why?
Hospitals
1
2021
637
0.130
 Why?
Genital Neoplasms, Female
1
2017
82
0.130
 Why?
Patient Reported Outcome Measures
1
2019
373
0.130
 Why?
Tomography, Emission-Computed, Single-Photon
1
2016
77
0.120
 Why?
Cannabis
1
2023
465
0.120
 Why?
Adenoma
1
2017
214
0.120
 Why?
Carcinoma, Non-Small-Cell Lung
1
2023
1052
0.120
 Why?
Radiosurgery
1
2018
321
0.120
 Why?
Patient Readmission
1
2019
667
0.110
 Why?
Phenotype
1
2002
3076
0.110
 Why?
Antineoplastic Agents
3
2021
2061
0.110
 Why?
Anti-Bacterial Agents
1
2004
1717
0.110
 Why?
Delivery of Health Care
1
2021
894
0.110
 Why?
Hospital Mortality
4
2024
850
0.110
 Why?
Morbidity
4
2021
302
0.110
 Why?
Unnecessary Procedures
1
2014
48
0.110
 Why?
Trauma Centers
2
2014
402
0.110
 Why?
Abdomen
1
2013
118
0.100
 Why?
Radiation Dosage
1
2014
153
0.100
 Why?
Clinical Competence
1
2019
1017
0.100
 Why?
Renal Insufficiency
1
2013
149
0.090
 Why?
Severity of Illness Index
3
2025
2742
0.090
 Why?
Asia
2
2021
58
0.090
 Why?
Triage
1
2012
206
0.090
 Why?
Age Factors
4
2022
3144
0.080
 Why?
Carcinoma, Renal Cell
1
2012
180
0.080
 Why?
Europe
2
2021
364
0.080
 Why?
Logistic Models
2
2025
1988
0.080
 Why?
Kidney Transplantation
2
2013
672
0.080
 Why?
Organ Preservation Solutions
2
2006
45
0.080
 Why?
Brain Injuries
1
2014
468
0.080
 Why?
Graft Survival
2
2009
512
0.080
 Why?
Practice Patterns, Physicians'
1
2017
1266
0.080
 Why?
Diagnostic Tests, Routine
2
2024
102
0.080
 Why?
Laparotomy
1
2008
106
0.070
 Why?
Bile Ducts, Extrahepatic
1
2008
22
0.070
 Why?
Kidney Neoplasms
1
2012
350
0.070
 Why?
Biliary Tract Surgical Procedures
1
2008
25
0.070
 Why?
Case-Control Studies
2
2007
3381
0.070
 Why?
Neoplasm Invasiveness
3
2020
485
0.070
 Why?
Intraoperative Care
1
2007
46
0.070
 Why?
Young Adult
7
2022
12426
0.070
 Why?
Cholangitis, Sclerosing
1
2008
71
0.070
 Why?
Electrocoagulation
1
2007
38
0.070
 Why?
Anus Neoplasms
1
2007
30
0.070
 Why?
Guideline Adherence
2
2024
526
0.070
 Why?
Congenital Hypothyroidism
1
1986
11
0.070
 Why?
Brazil
2
2008
154
0.070
 Why?
Multivariate Analysis
2
2025
1502
0.070
 Why?
Ultrasonography, Interventional
1
2007
128
0.070
 Why?
Fluorouracil
2
2022
199
0.060
 Why?
Wounds and Injuries
1
2012
711
0.060
 Why?
Mycophenolic Acid
1
2006
110
0.060
 Why?
Pandemics
2
2023
1488
0.060
 Why?
Adolescent
9
2022
20393
0.060
 Why?
Chemotherapy, Cancer, Regional Perfusion
1
2024
26
0.060
 Why?
Serum Albumin, Human
1
2024
6
0.060
 Why?
Platelet Count
1
2024
82
0.060
 Why?
Sample Size
1
2025
116
0.060
 Why?
Lymphocyte Count
1
2024
148
0.060
 Why?
Radiotherapy, Adjuvant
2
2019
210
0.050
 Why?
Zygomycosis
1
2003
6
0.050
 Why?
Gastrectomy
1
2024
100
0.050
 Why?
Bile Ducts, Intrahepatic
1
2024
65
0.050
 Why?
Developmental Disabilities
1
1986
261
0.050
 Why?
Cluster Analysis
1
2025
482
0.050
 Why?
Comorbidity
2
2022
1547
0.050
 Why?
Antibiotic Prophylaxis
1
2004
101
0.050
 Why?
Hepatocytes
1
2004
216
0.050
 Why?
Lymphocytes
1
2024
377
0.050
 Why?
Appendicitis
1
2004
125
0.050
 Why?
Biology
1
2023
85
0.050
 Why?
Capecitabine
1
2022
46
0.050
 Why?
Pneumonectomy
1
2023
151
0.050
 Why?
Carcinoma, Squamous Cell
1
2007
626
0.050
 Why?
Anesthesia, Intravenous
1
2021
14
0.050
 Why?
Anesthetics, Intravenous
1
2021
44
0.050
 Why?
Esophagogastric Junction
1
2021
50
0.040
 Why?
Surgical Wound Infection
1
2004
283
0.040
 Why?
Models, Biological
1
2008
1722
0.040
 Why?
Induction Chemotherapy
1
2021
70
0.040
 Why?
Body Mass Index
2
2024
2273
0.040
 Why?
Liver
2
2006
1839
0.040
 Why?
Thoracoscopy
1
2020
52
0.040
 Why?
Medical Oncology
1
2022
272
0.040
 Why?
Societies, Medical
1
2024
751
0.040
 Why?
Image-Guided Biopsy
1
2019
37
0.040
 Why?
Adenocarcinoma, Mucinous
1
2020
75
0.040
 Why?
Preoperative Period
1
2019
115
0.040
 Why?
Biomarkers, Tumor
1
2024
1181
0.040
 Why?
Perioperative Period
1
2017
49
0.040
 Why?
Oxidative Stress
1
2004
1269
0.030
 Why?
Carcinoma, Lobular
1
2017
48
0.030
 Why?
Occipital Bone
1
2017
18
0.030
 Why?
Operative Time
1
2017
124
0.030
 Why?
Parotid Gland
1
2017
22
0.030
 Why?
Gastric Emptying
1
2017
40
0.030
 Why?
Obesity
1
2010
2883
0.030
 Why?
Health Behavior
1
2002
741
0.030
 Why?
Longitudinal Studies
1
2024
2717
0.030
 Why?
Neck
1
2017
94
0.030
 Why?
Perioperative Care
1
2018
152
0.030
 Why?
Sex Factors
1
2022
1968
0.030
 Why?
Raffinose
2
2006
23
0.030
 Why?
Allopurinol
2
2006
62
0.030
 Why?
Glucose
1
2020
1003
0.030
 Why?
Consensus
1
2017
616
0.030
 Why?
Adenosine
2
2006
227
0.030
 Why?
Glutathione
2
2006
348
0.030
 Why?
Drug Administration Schedule
1
2015
769
0.030
 Why?
Cross-Sectional Studies
2
2022
5066
0.030
 Why?
Glasgow Coma Scale
1
2014
167
0.030
 Why?
Magnetic Resonance Imaging
1
2025
3408
0.030
 Why?
Radiation Injuries
1
2014
135
0.030
 Why?
Incidence
1
2019
2644
0.030
 Why?
Vital Signs
1
2012
41
0.020
 Why?
New South Wales
1
2012
14
0.020
 Why?
Child
6
2014
20883
0.020
 Why?
Baltimore
1
2012
45
0.020
 Why?
Disease Progression
1
2020
2635
0.020
 Why?
Italy
1
2012
100
0.020
 Why?
Child, Preschool
4
2014
10517
0.020
 Why?
Hospital Costs
1
2012
114
0.020
 Why?
Pharmaceutical Preparations
1
2013
171
0.020
 Why?
Biological Therapy
1
2011
28
0.020
 Why?
Albuminuria
1
1992
183
0.020
 Why?
Chi-Square Distribution
1
2012
516
0.020
 Why?
Injury Severity Score
1
2012
509
0.020
 Why?
Lung
1
2023
3930
0.020
 Why?
Surveys and Questionnaires
1
2022
5406
0.020
 Why?
Glomerular Filtration Rate
1
2013
711
0.020
 Why?
Infant, Newborn
2
2014
5762
0.020
 Why?
Carcinoembryonic Antigen
1
2008
41
0.020
 Why?
Immunosuppressive Agents
1
2013
853
0.020
 Why?
Antimetabolites, Antineoplastic
1
2008
91
0.020
 Why?
Radiopharmaceuticals
1
2008
168
0.020
 Why?
Sensitivity and Specificity
1
2012
1838
0.020
 Why?
Fluorodeoxyglucose F18
1
2008
129
0.020
 Why?
Infant
3
2014
9024
0.020
 Why?
Colorado
1
2017
4421
0.020
 Why?
Retreatment
1
2007
70
0.020
 Why?
Cholecystectomy
1
2007
59
0.020
 Why?
Positron-Emission Tomography
1
2008
288
0.020
 Why?
Incidental Findings
1
2007
79
0.020
 Why?
Neoplasm, Residual
1
2007
120
0.020
 Why?
Biopsy, Needle
1
2007
189
0.020
 Why?
Hepatitis B
1
2007
63
0.020
 Why?
Tablets, Enteric-Coated
1
2006
6
0.020
 Why?
Histidine
1
2006
60
0.020
 Why?
Radiography
1
2008
798
0.020
 Why?
Psychological Tests
1
1986
133
0.020
 Why?
Overweight
1
2010
531
0.020
 Why?
Graft Rejection
1
2009
598
0.010
 Why?
Tryptophan
1
2006
179
0.010
 Why?
Insulin
2
2006
2326
0.010
 Why?
Glutathione Disulfide
1
2004
32
0.010
 Why?
Hepatitis C
1
2007
238
0.010
 Why?
Sulfamethoxypyridazine
1
1983
1
0.010
 Why?
Trimethoprim
1
1983
7
0.010
 Why?
Gastrointestinal Diseases
1
2006
198
0.010
 Why?
Liver Function Tests
1
2004
112
0.010
 Why?
Anti-Infective Agents, Urinary
1
1983
13
0.010
 Why?
Amphotericin B
1
2003
29
0.010
 Why?
Liver Diseases
1
2006
290
0.010
 Why?
Patient Selection
1
2007
663
0.010
 Why?
Antifungal Agents
1
2003
129
0.010
 Why?
Cause of Death
1
2004
393
0.010
 Why?
Immunocompromised Host
1
2003
198
0.010
 Why?
Urinary Tract Infections
1
1983
152
0.010
 Why?
Reperfusion Injury
1
2004
272
0.010
 Why?
Cardiovascular Diseases
1
1992
2004
0.010
 Why?
Diabetes Mellitus, Type 1
1
1992
3628
0.010
 Why?
Cholesterol
1
1992
412
0.010
 Why?
Blood Pressure
1
1992
1736
0.000
 Why?
Sulfamethoxazole
1
1983
7
0.000
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
1983
37
0.000
 Why?
Escherichia coli Infections
1
1983
112
0.000
 Why?
Drug Combinations
1
1983
330
0.000
 Why?
Microbial Sensitivity Tests
1
1983
352
0.000
 Why?
Escherichia coli
1
1983
774
0.000
 Why?
Clinical Trials as Topic
1
1983
1004
0.000
 Why?
Gleisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (332) concept(s)
_
Co-Authors Expand Description
See all (43) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)